Cite
HARVARD Citation
Li, Z. et al. (2013). FRI0211 Safety and efficacy of subcutaneous golimumab in chinese patients with active rheumatoid arthritis despite mtx therapy: results from a randomized, placebo-controlled, phase 3 trial. Annals of the rheumatic diseases. p. A444. [Online].